Gut bacteria study for people with ALS
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study looks at the bacteria in your gut (microbiome) to see if they are linked to different symptoms or types of ALS. It may help doctors understand more about the disease and could lead to better treatments in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have ALS that is possible, probable, or definite according to standard diagnostic criteria.
- You are being followed at one of the 18 participating ALS expert centers in France.
- You are at least 18 years old.
- You are covered by French social security or are a beneficiary.
- You agree to take part in the French Gut project, which involves registering online, completing a questionnaire, and sending a stool sample.
- You have not had a colectomy, do not have a digestive stoma, have not had a colonoscopy in the last 3 months, and have not taken antibiotics in the last 3 months (if not already in French Gut).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a comprehensive analysis platform to better understand ALS (and related conditions) and help find ways to “remedy and eliminate” it. If you have ALS or are a healthy control who can safely complete questionnaires and possibly an MRI, you may be able to contribute data that researchers use to improve care.
This study looks at immune cells (called macrophages) from people with ALS and certain related movement or nerve conditions. It aims to better understand how the disease works and may help researchers design future treatments.
This study looks at why some people with ALS lose weight and what factors are involved. It follows patients in France and Germany to better understand weight changes and help improve care.
This study collects a small skin sample (biopsy) from people with ALS, those who carry an ALS gene mutation but have no symptoms, and healthy volunteers. The sample is used to grow cells in the lab to better understand how ALS develops.
This trial collects blood and spinal fluid samples from people being checked for ALS. The goal is to find clues (biomarkers) in tiny particles from nerve cells that could help doctors better understand and diagnose ALS.
This study follows people with ALS and healthy volunteers to measure how specific body fluids, symptoms, and at-home tracking change over time. It may help researchers find early signs of disease changes and better ways to measure treatment effects.
Hear when a new Amyotrophic Lateral Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.